Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Depreciation & Amortization (CF) (2018 - 2025)

Cryo Cell International (CCEL) has disclosed Depreciation & Amortization (CF) for 14 consecutive years, with $243011.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 2.4% to $243011.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $985242.0, a 42.0% increase, with the full-year FY2025 number at $985242.0, up 42.0% from a year prior.
  • Depreciation & Amortization (CF) was $243011.0 for Q4 2025 at Cryo Cell International, roughly flat from $244090.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $396112.0 in Q1 2022 to a low of $72489.0 in Q1 2021.
  • A 5-year average of $280837.2 and a median of $319708.0 in 2021 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): soared 446.44% in 2022, then crashed 76.74% in 2024.
  • Cryo Cell International's Depreciation & Amortization (CF) stood at $327200.0 in 2021, then grew by 12.8% to $369079.0 in 2022, then dropped by 8.99% to $335896.0 in 2023, then decreased by 25.87% to $248997.0 in 2024, then fell by 2.4% to $243011.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Depreciation & Amortization (CF) are $243011.0 (Q4 2025), $244090.0 (Q3 2025), and $250131.0 (Q2 2025).